http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2711358-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_617fdbb3f837da071137feb6e131fd27 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62 |
| filingDate | 2014-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffd31d38f80bf55d4593a1fded5ec5ba |
| publicationDate | 2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2711358-T3 |
| titleOfInvention | Prognostic marker to determine the risk of early onset preeclampsia |
| abstract | An in vitro procedure to identify, from a biological fluid sample of a pregnant female, a pregnancy-related syndrome selected from the group consisting of preeclampsia of early onset, eclampsia and hemolysis, increased liver enzymes and thrombocytopenia (HELLP), including the procedure (i) measuring the amount of ESM-1 in the biological sample, proceeding the biological sample of the pregnant female in any one of the weeks 9-16 of gestation; (ii) compare said amount of ESM-1 with a reference value, and (iii) identify, based on the comparison of the amount of ESM-1 with the reference value, if it is probable that the female has or develops the syndrome related to pregnancy, said biological fluid sample comprising a blood sample, a plasma sample or a serum sample of said pregnant female. |
| priorityDate | 2013-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 249.